Industry reports
Editor highlights

Search inside this page

Publishers

All regions

Free Market Research Guides to Download

Biotechnology Analysis & Statistics, March 2014 (p2)

You might be interested in: biotech, biomedical, protein, more »

» Purchase Premium Reports

31-60 of about 3 100 reports
Regenerative medicine and Stem cells Partnering Terms and Agreements

Regenerative medicine and Stem cells Partnering Terms and Agreements

  • $ 2 995
  • Industry report
  • March 2014
  • by Currentpartnering

The Regenerative Medicine and Stem Cells Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the Regenerative medicine and Stem cells partnering deals ...

  • Industries : Biological Therapy
Genetic Disorders Partnering Terms and Agreements

Genetic Disorders Partnering Terms and Agreements

  • $ 2 995
  • Industry report
  • March 2014
  • by Currentpartnering

The report will be delivered in PDF format within 3 working days of receipt of order. If print or CD-Rom version purchased, the report will be sent by courier using express service. The Genetic Disorders ...

  • Industries : Genetically Modified Organism, Gmo
Ortho and Osteobiologics: World Industry and Market Analysis 2014-2024

Ortho and Osteobiologics: World Industry and Market Analysis 2014-2024

  • $ 2 776
  • Industry report
  • January 2014
  • by Visiongain

Report Details Biotechnology for bone disorders - new study showing you trends, R&D progress, and predicted revenues What's the future of orthobiologics and osteobiologics? Visiongain's updated report ...

  • Industries : Biomaterial, Blood Supply, Tissue Banking and Transplantation
  • Countries : World
Trastuzumab: Pipeline™ Developer: Patent Report

Trastuzumab: Pipeline™ Developer: Patent Report

  • $ 2 529
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Biological Therapy
United States Orthobiologics Market Outlook to 2020

United States Orthobiologics Market Outlook to 2020

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

United States Orthobiologics Market Outlook to 2020 Summary GlobalData's new report, "United States Orthobiologics Market Outlook to 2020", provides key market data on the United States Orthobiologics ...

  • Industries : Biomaterial, Blood Supply, Tissue Banking and Transplantation
  • Countries : United States
Erythropoietin: Pipeline™ Developer: Patent Report

Erythropoietin: Pipeline™ Developer: Patent Report

  • $ 2 266
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Biopharmaceutical
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2014

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • March 2014
  • by Global Markets Direct

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2014', provides an overview of the Retinitis Pigmentosa ...

  • Industries : Biological Therapy
  • Countries : United States, World
Pain Partnering 2009-2014

Pain Partnering 2009-2014

  • $ 1 995
  • Industry report
  • March 2014
  • by Currentpartnering

The report will be delivered in PDF format within 3 working days of receipt of order. If print or CD-Rom version purchased, the report will be sent by courier using express service. The Pain Partnering ...

  • Industries : Biotechnology
Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325414

Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325414

  • $ 1 995
  • Industry report
  • February 2014
  • by Plunkett Research

Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325414 Vital industry-specific ...

  • Industries : Biopharmaceutical
  • Countries : United States
Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

The androgen receptor signaling pathway activates the SMAD signaling module. There are today 327 companies plus partners developing 426 Androgen Receptor drugs in 1397 developmental projects in cancer. ...

  • Industries : Biological Therapy
Notch Signaling Pathway in Oncology Drug Pipeline Update 2014

Notch Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Aberrant Notch signaling has been linked to a number of malignancies including leukemias, lymphomas and carcinomas of the breast, skin, lung, cervix and kidneys. There are today 249 companies plus partners ...

  • Industries : Biological Therapy
B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Activation of the B cell receptor involves phosphorylation of the cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs) present in Ig alpha and beta. This leads to activation of several non-recepto ...

  • Industries : Biological Therapy
T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Stimulation of the T cell receptor leads to the activation of NFkB and NFAT signaling modules which play a key role in T cell receptor signaling. There are today 242 companies plus partners developing ...

  • Industries : Biological Therapy
Interfering With Cytokine-Cytokine Receptor Interaction for the Treatment of Cancer Drug Pipeline Update 2014

Interfering With Cytokine-Cytokine Receptor Interaction for the Treatment of Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Cytokines are soluble extracellular proteins or glycoproteins that are crucial intercellular regulators and mobilizers of cells engaged in innate as well as adaptive inflammatory host defenses, cell growth, ...

  • Industries : Biological Therapy
EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2014

EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

The EGFR1 signaling pathway activates the Ras/Raf/MAPK signaling modules. There are today 365 companies plus partners developing 620 EGFR1 pathway targeting drugs in 2313 developmental projects in cancer. ...

  • Industries : Biological Therapy
TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

The TGF-beta receptor signaling pathway activates the MAPK/SMAD signaling modules. There are today 288 companies plus partners developing 403 TGF-beta receptor pathway targeting drugs in 1356 developmental ...

  • Industries : Biological Therapy
Antibodies in Oncology: Drug Pathway Analyzer 2014

Antibodies in Oncology: Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 608 antibody drugs known to affect more than 206 specific intracellular signaling pathways for the treatment ...

  • Industries : Biopharmaceutical
Antibodies in Oncology Drug Pipeline Update 2014

Antibodies in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the ...

  • Industries : Biopharmaceutical
Hedgehog Signaling Pathway in Oncology Drug Pipeline Update 2014

Hedgehog Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Aberrant activation of the Hedgehog pathway has been associated with a number of human malignancies including carcinoma of lung, esophagus, pancreas and prostate. There are today 119 companies plus partners ...

  • Industries : Biological Therapy
TNF-Alpha Signaling Pathway in Oncology Drug Pipeline Update 2014

TNF-Alpha Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

The TNF-alfa signaling pathway stimulates the MAPK signaling module and activates NFkB. There are today 359 companies plus partners developing 531 TNF-alpha pathway targeting drugs in 1960 developmental ...

  • Industries : Biological Therapy
Wnt Signaling Pathway in Oncology Drug Pipeline Update 2014

Wnt Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Abnormalities in the Wnt signaling pathway are associated with a large variety of human malignancies including tumors of breast, colon, pancreas, liver and bone. There are today 178 companies plus partners ...

  • Industries : Biological Therapy
Cancer Stem Cells Drug Pipeline Update 2014

Cancer Stem Cells Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Treatments designed to target and destroy cancer stem cells may come to revolutionize how we treat cancer. This unique product covers both explicit cancer stem cell drug development and cancer drugs which ...

  • Industries : Biological Therapy
Gene Therapy in Oncology Drug Pipeline Update 2014

Gene Therapy in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

There are today 121 companies plus partners developing 109 gene therapy drugs in 278 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs ...

  • Industries : Biological Therapy
Global and China Industrial Enzyme Industry Report, 2014-2016

Global and China Industrial Enzyme Industry Report, 2014-2016

  • $ 1 800
  • Industry report
  • February 2014
  • by Research In China

In 2007-2013, the global industrial enzyme market size grew at the CAGR of 5.7%, reaching USD4.04 billion in 2013, 1.4 times that in 2007. The global industrial enzyme market is monopolized by a small ...

  • Industries : Biopharmaceutical
  • Countries : China
Inflammatory Partnering 2009-2014

Inflammatory Partnering 2009-2014

  • $ 1 795
  • Industry report
  • March 2014
  • by Currentpartnering

The report will be delivered in PDF format within 3 working days of receipt of order. If print or CD-Rom version purchased, the report will be sent by courier using express service. Inflammatory Partnering ...

  • Industries : Biotechnology
SK Biopharmaceuticals Co., Ltd. - Product Pipeline Review - 2014

SK Biopharmaceuticals Co., Ltd. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • March 2014
  • by Global Markets Direct

SK Biopharmaceuticals Co., Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘SK Biopharmaceuticals Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the SK B ...

  • Industries : Biopharmaceutical
  • Countries : World
Panacea Biotec Limited - Product Pipeline Review - 2014

Panacea Biotec Limited - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • March 2014
  • by Global Markets Direct

Panacea Biotec Limited - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Panacea Biotec Limited - Product Pipeline Review - 2014', provides an overview of the Panacea Biotec Limited's ...

  • Industries : Biopharmaceutical
  • Countries : World
Global Biosimilar Market Outlook 2018

Global Biosimilar Market Outlook 2018

  • $ 1 500
  • Industry report
  • February 2014
  • by RNCOS

The global biosimilars market is at a crucial turning point, as biosimilars are gaining wide acceptance around the world, with regulatory pathways being clearly defined in every region and R&D investments ...

  • Industries : Biopharmaceutical
  • Countries : World
MedImmune, LLC - Product Pipeline Review - 2014

MedImmune, LLC - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • January 2014
  • by Global Markets Direct

MedImmune, LLC - Product Pipeline Review - 2014 Summary Global Market Direct's pharmaceuticals report, “MedImmune, LLC - Product Pipeline Review - 2014” provides data on the MedImmune, LLC's research ...

  • Industries : Biopharmaceutical
  • Countries : World
Next Generation Sequencing in Latin America

Next Generation Sequencing in Latin America

  • $ 1 500
  • Industry report
  • January 2014
  • by Kalorama Information

This report, Next Generation Sequencing in Latin America, is a look at the use of DNA sequencing systems in the region, based on Survey conducted by VA Consultadoros in Fall 2013. The survey focused on ...

  • Industries : Genomics
  • Countries : South America

» Read our Company Profiles

About 100 Companies

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Biogen Idec

United States

Merck KGaA

Germany

Abbott Laboratories

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.